-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Conmed, Lowers Price Target to $57

Benzinga·05/01/2025 15:28:35
Listen to the news
Wells Fargo analyst Vik Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $70 to $57.